2006
DOI: 10.1016/j.ejmech.2006.03.010
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and evaluation of cytotoxic activity of arylfurans

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
13
0

Year Published

2006
2006
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 19 publications
(13 citation statements)
references
References 17 publications
0
13
0
Order By: Relevance
“…For certain substrates, the Ti III -mediated arylation of furans with diazonium salts might have potential as a useful alternative. [14] It has been reported, though, that Meerwein-type arylation reactions cannot be applied to the synthesis of 2,5-diarylfurans such as 6 or 9, [7] which have instead been synthesized from symmetrical 2,5-distannylfurans [15] in double Stille couplings. The disadvantages of this method include potential contamination of the products with organostannane residues, as well as selectivity issues arising when the method is adopted for the synthesis of unsymmetrical 2,5-diarylfurans.…”
Section: Introductionmentioning
confidence: 97%
See 1 more Smart Citation
“…For certain substrates, the Ti III -mediated arylation of furans with diazonium salts might have potential as a useful alternative. [14] It has been reported, though, that Meerwein-type arylation reactions cannot be applied to the synthesis of 2,5-diarylfurans such as 6 or 9, [7] which have instead been synthesized from symmetrical 2,5-distannylfurans [15] in double Stille couplings. The disadvantages of this method include potential contamination of the products with organostannane residues, as well as selectivity issues arising when the method is adopted for the synthesis of unsymmetrical 2,5-diarylfurans.…”
Section: Introductionmentioning
confidence: 97%
“…[6] Apart from these clinically approved drugs, numerous other 2-aryl-, 2-alkyl-5-aryl-and 2,5-diarylfurans have been investigated as drug candidates in medicinal chemistry studies over the past decade. These compounds ( Figure 2) were tested for diverse applications, such as activity against several cancer cell lines (compounds 5 and 6), [7] cardioprotective activity through inhibition of Na + /H + exchangers (7), [8,9] activity as an HIV-integrase inhibitor (8), [10,11] activity against Mycobacterium tuberculosis (9) [12] or as potential therapeutics for smoking cessation (10). [13] [a] Universität Potsdam, Institut für Chemie (Organische Synthesechemie Because of the low to moderate yields normally observed for Meerwein arylation reactions of furans, this method is restricted to cheap or conveniently available starting materials.…”
Section: Introductionmentioning
confidence: 99%
“…These compounds have been considered important scaffolds in molecular modification studies due to their antileishmanial and antichagasic activities [13][14][15][16]. Cassamale et al [12] demonstrated the antileishmanial activity of these triazole derivatives on promastigote forms; now the present work shows their activity on L. (L.) amazonensis intracellular amastigotes, searching for structure-activity relationship information to support the development of new drug candidates for CL.…”
Section: Introductionmentioning
confidence: 84%
“…arylfurans include numerous compounds exhibiting interesting biological and pharmacological activities. [13] For instance, the 2-arylfuran derivative 1 (dantrolene) ( Figure 1) is a muscle relaxant commonly used for the treatment of life-threatening complications during anesthesia; [14] compound 2 ( Figure 1) effectively inhibits infection by both laboratory-adapted and primary HIV-1 strains and blocks HIV-1 mediated cell-cell fusion and gp41 six-helix bundle formation; [15] azofuran 3 ( Figure 1) possesses significant activity against cancer cells without affecting the lymphocyte proliferation in human peripheral blood mononuclear cells; [16] the 3-substituted (5-arylfuran-2-ylcarbonyl)-guanidine 4 ( Figure 1) exhibits high Na + /H + exchange isoform-1 inhibitory activity; [17] and bioymifi (5) (Figure 1) is a compound that binds to the extracellular domain of the DR 5 receptors and induces their aggregation. [18] In 2009, Doucet and co-workers reported that 2-butyl-5-arylfurans could be selectively prepared by the reaction of 2 equiv.…”
Section: A C H T U N G T R E N N U N G (Hetero)arylation Of Furan Andmentioning
confidence: 99%